A growing body of evidence warns about the health effects of ultra-processed foods (UPFs), and a new study has now linked high intake of these products with a significantly increased risk of lung cancer.
The research, published in Thorax, found that people who consumed the highest amounts of UPFs had a 41% higher likelihood of developing lung cancer compared with those who ate the least.
UPFs are formulations of food substances that undergo heavy industrial processing and include additives such as flavors, colors, emulsifiers, and preservatives. They are designed to be hyper-palatable and ready-to-consume.
These foods make up around 60% of daily energy intake in the United States, according to prior research.
The researchers analyzed dietary data from more than 100,000 participants enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). Participants were followed for an average of 12.2 years.
Those in the highest quartile of UPF intake showed a 41% increased risk of lung cancer compared with the lowest quartile.
The study authors and independent experts suggest several possible reasons:
Additionally, people consuming higher amounts of UPFs tended to eat fewer fruits, vegetables, and whole grains, which are known to lower cancer risk.
Experts caution that this was an observational study, meaning it cannot prove cause and effect. Limitations include:
Dr. Nilesh Vora, medical director of the MemorialCare Todd Cancer Institute in California, noted that while the findings are compelling, more prospective studies are needed to validate the results.
Despite the uncertainties, experts agree that reducing UPF intake benefits overall health. Prior reviews have linked these foods to higher risks of:
Katrina Brown of Cancer Research UK emphasized:
“Cutting down on these types of foods can be part of a healthy, balanced diet. When it comes to lung cancer, not smoking remains the most effective way to lower risk.”
CLICK HERE TO FOLLOW Medical News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and medical breakthroughs—delivered directly to you.